Drug profile · INN
cenegermin
OXERVATE
cenegermin (OXERVATE) is a neurotrophic tyrosine kinase receptor agonist.
EMA: approved Sensory organs (S01) S01
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — cenegermin
- Class
- Sensory organs (S01)
- Route
- —
- Patents
- 0
- Programs
- 3
- Data quality
- 0.83
Quick answer
cenegermin (OXERVATE) is a neurotrophic tyrosine kinase receptor agonist.
Key facts
INN cenegermin
Brand OXERVATE
Mechanism Neurotrophic tyrosine kinase receptor agonist
Target Neurotrophic tyrosine kinase receptor
Therapeutic class Sensory organs (S01)
ATC code S01
Mechanism of action
Neurotrophic tyrosine kinase receptor agonist
Primary target: Neurotrophic tyrosine kinase receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is cenegermin?
cenegermin (OXERVATE) is a neurotrophic tyrosine kinase receptor agonist.
What is the brand name for cenegermin?
OXERVATE is a marketed brand name for cenegermin. Check FDA Drugs@FDA for the current US label holder and prescribing information.